Literature DB >> 2457586

Isolation and characterization of the human thyrotropin beta-subunit gene. Differences in gene structure and promoter function from murine species.

F E Wondisford1, S Radovick, J M Moates, S J Usala, B D Weintraub.   

Abstract

The human thyrotropin beta-subunit gene was isolated and characterized from two genomic libraries and found to contain three exons separated by two introns of 3.9 and 0.45 kilobase pairs. Exons 2 and 3 in the mouse thyrotropin beta-subunit gene are not found in humans due to a lack of consensus sequences important in exon splicing. Moreover, using primer extension, RNA sequencing, and S1 nuclease analysis, we determined, in a thyrotropin-producing pituitary adenoma, that exon 1 in humans contains only one transcriptional start site and is 37 base pairs in length. This is unlike both the rat and mouse thyrotropin beta-subunit genes which contain two transcriptional start sites. Changes in the genomic structure of the more 5' "TATA box" and surrounding "CAAT box" might explain why the more 5' start site in humans is apparently not utilized. Moreover, the first exon in humans is longer than the corresponding exon in murine species presumably due to a 9-base pair insertion between the TATA box and transcriptional start site (37 versus 27 nucleotides). Thus, while alternative exon splicing and differential start site utilization in response to thyroid hormone may be important in the regulation of murine thyrotropin beta-subunit genes, they are not found in man.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 2457586

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  15 in total

Review 1.  The use of recombinant human thyrotropin (rhTSH) in the management of differentiated thyroid cancer.

Authors:  M C Skarulis
Journal:  Rev Endocr Metab Disord       Date:  2000-04       Impact factor: 6.514

Review 2.  Molecular structures of glycoprotein hormones and functions of their carbohydrate components.

Authors:  A Stockell Hartree; A G Renwick
Journal:  Biochem J       Date:  1992-11-01       Impact factor: 3.857

3.  A soluble transcription factor, Oct-1, is also found in the insoluble nuclear matrix and possesses silencing activity in its alanine-rich domain.

Authors:  M K Kim; L A Lesoon-Wood; B D Weintraub; J H Chung
Journal:  Mol Cell Biol       Date:  1996-08       Impact factor: 4.272

Review 4.  Genetic aspects of central hypothyroidism.

Authors:  R Collu
Journal:  J Endocrinol Invest       Date:  2000-02       Impact factor: 4.256

5.  Mediator subunit MED1 is a T3-dependent and T3-independent coactivator on the thyrotropin β gene promoter.

Authors:  Keiji Matsui; Kasumi Oda; Shumpei Mizuta; Ruri Ishino; Norinaga Urahama; Natsumi Hasegawa; Robert G Roeder; Mitsuhiro Ito
Journal:  Biochem Biophys Res Commun       Date:  2013-09-18       Impact factor: 3.575

Review 6.  Historical note: many steps led to the 'discovery' of thyroid-stimulating hormone.

Authors:  James Magner
Journal:  Eur Thyroid J       Date:  2014-03-13

7.  Recombinant human thyrotropin use resulting in ovarian hyperstimulation: an unusual side effect.

Authors:  Tanvir Rizvi; Patrice K Rehm
Journal:  Eur Thyroid J       Date:  2014-06-07

8.  Zebrafish as a model for monocarboxyl transporter 8-deficiency.

Authors:  Gad David Vatine; David Zada; Tali Lerer-Goldshtein; Adi Tovin; Guy Malkinson; Karina Yaniv; Lior Appelbaum
Journal:  J Biol Chem       Date:  2012-11-16       Impact factor: 5.157

9.  Recombinant thyrotropin for detection of recurrent thyroid cancer.

Authors:  Paul W Ladenson
Journal:  Trans Am Clin Climatol Assoc       Date:  2002

10.  Mutations of the human thyrotropin-beta subunit glycosylation site reduce thyrotropin synthesis independent of changes in glycosylation status.

Authors:  R W Lash; R K Desai; C A Zimmerman; M R Flack; T Yoshida; F E Wondisford; B D Weintraub
Journal:  J Endocrinol Invest       Date:  1992-04       Impact factor: 4.256

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.